MARKET

AZN

AZN

Astrazeneca Plc
NASDAQ
63.35
-0.18
-0.28%
Opening 10:27 02/07 EST
OPEN
63.24
PREV CLOSE
63.52
HIGH
63.46
LOW
63.19
VOLUME
909.70K
TURNOVER
0
52 WEEK HIGH
72.12
52 WEEK LOW
52.65
MARKET CAP
196.35B
P/E (TTM)
96.99
1D
5D
1M
3M
1Y
5Y
Roche's less frequently dosed crovalimab matches Soliris, meets phase 3 trial goals in rare blood disorder
Seeking Alpha · 16h ago
AstraZeneca Announced Forxiga Approved In The EU For The Treatment Of Symptomatic Chronic Heart Failure
Benzinga · 17h ago
AstraZeneca Forxiga approved for expanded use in EU for chronic heart failure
Seeking Alpha · 17h ago
AstraZeneca says Forxiga approved in EU for heart failure
MarketWatch · 19h ago
AstraZeneca's Forxiga Approved in Europe for Symptomatic Chronic Heart Failure
AstraZeneca's Forxiga Approved in Europe for Symptomatic Chronic Heart Failure
MT Newswires · 21h ago
Hutchmed: We Explore Pharma In China
Seeking Alpha · 1d ago
FOCUS-Drug companies face COVID cliff in 2023 as sales set to plummet
Reuters · 1d ago
PRESS DIGEST-British Business - Feb 6
Reuters · 2d ago
More
About AZN
AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Its pipeline forms a robust portfolio of investigational therapies in various stages of clinical development. Its pipeline includes the Alexion Rare Disease portfolio and comprises approximately 179 projects. Its key marketed oncology products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Zoladex, Faslodex and others. Its rare diseases products include Soliris, Ultomiris, Strensiq and Kanuma. Its BioPharmaceuticals products include Farxiga, Lokelma, Crestor, Breztri and others. Its geographical segments include United Kingdom, Rest of Europe, The Americas and Asia, Africa & Australasia. It is also focused on discovering, developing, and manufacturing of T-cell receptor therapies.

Webull offers kinds of AstraZeneca plc (ADR) stock information, including NASDAQ:AZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AZN stock methods without spending real money on the virtual paper trading platform.